BackPascal Biosciences Overview

Pascal Biosciences Other Current Liabilities

Track Pascal Biosciences's other current liabilities ($230K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$226528.00
↓ 17.38% YoYΔ $-47660.00 vs prior year quarter

Peer trimmed avg / median

Loading

Pascal Biosciences Other Current Liabilities History

Loading

Pascal Biosciences vs. peers: Other Current Liabilities Comparison

Loading

Pascal Biosciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pascal Biosciences (PSCBF) FAQ

The latest other current liabilities for PSCBF is $230K as of May 2026. That compares with $270K in the prior-year period — down 17.4% year over year. Investors often review this figure alongside Pascal Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, PSCBF's other current liabilities moved from $270K to $230K — a 17.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pascal Biosciences's operating scale or balance-sheet position.

A other current liabilities figure of $230K for PSCBF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PSCBF's other current liabilities ($230K), review year-over-year change from $270K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.